BluePath Capital Management’s Cencora COR Stock Holding History

BluePath Capital Management’s Portfolio COR Stock Details COR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-778	Closed	-$140K	–	148
2023 Q3	$140K	Buy	+778	New	+$144K	0.13%	125

Other funds holding COR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BluePath Capital Management's COR Position: Q4 2023 in Review

BluePath Capital Management sold out of Cencora (COR) in Q4 2023, closing a stake of 778 shares — an estimated $140K sold.

BluePath Capital Management first reported a position in COR in Q3 2023 and held it in 1 quarter. The position peaked at $140K in Q3 2023. 1,079 funds tracked by Wall St. Rank hold COR as of Q4 2023.

BluePath Capital Management reported no remaining Cencora position as of Q4 2023 after selling out during the quarter.
BluePath Capital Management sold 778 Cencora shares in Q4 2023, an estimated $140K.
BluePath Capital Management first reported a position in Cencora in Q3 2023 and held it in 1 quarter.
BluePath Capital Management's Cencora position peaked at $140K in Q3 2023.
1,079 funds tracked by Wall St. Rank held Cencora as of Q4 2023.

Based on BluePath Capital Management's 13F filing for Q4 2023, filed 11 Jan 2024.